Mission Statement: To advance understanding of complex conditions at the interface of neurology and psychiatry, drastically improve quality of life and ultimately provide a cure to those affected by developing and implementing new innovative approaches and therapies for disease of the nervous system.
Carolinas HealthCare System Behavioral Health - Charlotte, a facility of Carolinas Medical Center
501 Billingsley Road
Charlotte, NC 28211
Get Directions | View Map
Oleg Tcheremissine, MD has more than 25 years of clinical and research experience in the areas of neuropsychiatric and substance use disorders in the adult population.
He has served as the research director for the department of psychiatry and behavioral sciences at Carolinas Healthcare System since 2006 and as the principal investigator for numerous clinical trials for neuropsychiatric disorders. He successfully maintained extramural funding and awards since 2002.
His publications include over 30 articles in peer-review journals and numerous book chapters in the areas of human aggressive, impulsive and risk-taking behaviors and as well as clinical pharmacotherapy of Schizophrenia, Major Depressive Disorder, Bipolar Disorder, and Adult ADHD as well as other mental health care issues.
He is currently a member of the Editorial Board of World Journal of Psychiatry and active reviewer for 8 professional journals and has made numerous presentations at national and international professional meetings. He has been involved in the development of innovative approaches to recovery models of care, with a primary focus of integrating behavioral health into the primary care setting.
In addition to his clinical and research responsibilities, he is actively engaged in the teaching and training of physicians, students, and researchers.
He is a member of the American Society of Clinical Psychopharmacology and the International Society for CNS Clinical Trials and Methodology
|Board Certified:||American Board of Psychiatry and Neurology|
|Medical School:||Pediatric State Medical Institute-Leningrad, USSR|
|Residency:||College for the Advanced Medical Studies-Leningrad, USSR
Specialty: Psychiatry and Psychotherapy 1989-1992
The University of Texas-Houston Medical School
Targeting Cognitive Deficits in Schizophrenia: A Review of the Development of a New Class of Medicines from the Perspective of Community Mental Health Researchers.
Publication Year: 2012
Authors: Tcheremissine OV, Castro MA, Gardner DR
References: Expert Opinion in Investigational Drugs, 21(1):7-14
Is quetiapine a drug of abuse? Re-examining the issue of addiction.
Publication Year: 2008
Authors: Tcheremissine OV.
References: Expert Opinion on Drug Safety, 7 (6): 739-748.
Individual differences in aggressive responding to intravenous flumazenil administration in adult male parolees.
Publication Year: 2005
Authors: Tcheremissine OV, Cherek DR, Lane SL, Lieving LM, Rhoades H, Nouvion SO.
References: Journal of Psychopharmacology, 19: 640-647.
Acute marijuana effects on human risk taking.
Publication Year: 2005
Authors: Lane SD, Cherek DR, Tcheremissine OV, Lieving LM, Pietras CJ.
References: Neuropsychopharmacology, 30: 800-809.
Psychopharmacology of conduct disorder: current progress and future directions.
Publication Year: 2004
Authors: Tcheremissine OV, Cherek DR, Lane SD.
References: Expert Opinion in Pharmacotherapy 5: 1109-1116.
Impulsiveness and other personality dimensions in substance use disorders and conduct disorder.
Publication Year: 2003
Authors: Tcheremissine OV, Lane SD, Cherek DR, Pietras CJ.
References: Addictive Disorder and Their Treatment, 1:1-7.